Xianling Dai
Key Laboratory Of Biorheological Science And Technology, 400030, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Deoxyribonucleic Acid Activator-Triggered Entropy-Driven Catalysis-Modulated CRISPR/Cas12a-Based Portable Biosensor for Simultaneous Detection of Multiple Pathogenic Bacteria.
Journal: ACS sensors
Published: February 26, 2026
GTPBP8 mitigates nonalcoholic steatohepatitis (NASH) by depressing hepatic oxidative stress and mitochondrial dysfunction via PGC-1α signaling.
Journal: Free radical biology & medicine
Published: July 26, 2024
Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPARγ-driven lipid biosynthesis via regulating lipidome metabolic reprogramming.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 20, 2024
Integrating Pt nanoparticles with 3D Cu2- x Se/GO nanostructure to achieve nir-enhanced peroxidizing Nano-enzymes for dynamic monitoring the level of H2O2 during the inflammation.
Journal: Frontiers in immunology
Published: March 11, 2024
Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S-Palmitoylated IRHOM2.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 28, 2023
Corrigendum to "Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling" [Redox Biol. 51 (2022) 102274].
Journal: Redox biology
Published: November 10, 2023
Corrigendum to "Cynapanoside A exerts protective effects against obesity-induced diabetic nephropathy through ameliorating TRIM31-mediated inflammation, lipid synthesis and fibrosis" [Int. Immunopharmacol. 113 (Part B) (2022) 109395].
Journal: International immunopharmacology
Published: October 31, 2023
Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression.
Journal: Journal of hepatology
Published: July 07, 2023
Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S-Palmitoylated IRHOM2.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 03, 2023
Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C/EBPδ signalling activation.
Journal: Nature communications
Published: January 06, 2023
Cynapanoside A exerts protective effects against obesity-induced diabetic nephropathy through ameliorating TRIM31-mediated inflammation, lipid synthesis and fibrosis.
Journal: International immunopharmacology
Published: September 17, 2022
The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway.
Journal: Acta pharmaceutica Sinica. B
Published: July 08, 2022
Last Updated: 09/26/2026